Glenmark, Cipla receive approval to test experimental coronavirus vaccine

Mumbai based pharmaceutical company, Cipla got approval from the Indian regulators to experiment medicine, Favipiravir for COVID-19 in India. Around the globe, a lot of drugs are under clinical trials phases on corona virus patients, in order to develop some success against COVID-19. CSIR (Council of Scientific and Industrial Research) has identified top 25 drugs …